Sex difference in κ-Opioid Receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5′-O-(3-[ 35S]thiotriphosphate) binding in the guinea pig

Journal of Pharmacology and Experimental Therapeutics

Volumn 339, Issue 2, 2011, Pages 438-450

  Wang, Yu Jun ^a   Rasakham, Khampaseuth ^a   Huang, Peng ^a   Chudnovskaya, Darina ^a   Cowan, Alan ^a   Liu Chen, Lee Yuan ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL) CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; U50 488H; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BRAIN REGION; CAUDATE NUCLEUS; CEREBELLUM; CLAUSTRUM; CONTROLLED STUDY; DENTATE GYRUS; DRUG BINDING; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; FEMALE; GENICULATE NUCLEUS; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANALGESICS, NON-NARCOTIC; ANIMALS; BRAIN; COCAINE; DOPAMINE UPTAKE INHIBITORS; FEMALE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GUINEA PIGS; MALE; MICE; MOTOR ACTIVITY; MOVEMENT; NALTREXONE; NARCOTIC ANTAGONISTS; POSTURE; RATS; RECEPTORS, OPIOID, KAPPA; SEX CHARACTERISTICS;

EID: 80054786951     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.183905     Document Type: Article

References (85)

1. Arita J and Porter JC (1984) Relationship between dopamine release into hypophysial portal blood and prolactin release after morphine treatment in rats. Neuroendocrinology 38:62-67.
2. Asher IM and Aghajanian GK (1974) 6-Hydroxydopamine lesions of olfactory tubercles and caudate nuclei: effect on amphetamine-induced stereotyped behavior in rats. Brain Res 82:1-12.
3. Barrett AC, Smith ES, and Picker MJ (2002) Sex-related differences in mechanical nociception and antinociception produced by μ- and κ-opioid receptor agonists in rats. Eur J Pharmacol 452:163-173.
4. Binder W, Carmody J, and Walker J (2000) Effect of gender on anti-inflammatory and analgesic actions of two κ-opioids. J Pharmacol Exp Ther 292:303-309.
5. Bot G, Chahl LA, Brent PJ, and Johnston PA (1992) Effects of intracerebroventricularly administered μ-, δ- and κ-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H. Neuropharmacology 31:825-833.
6. Brent PJ and Bot G (1992) Morphine, D-Pen2, D-Pen5 enkephalin and U50,488H differentially affect the locomotor activity and behaviours induced by quinpirole in guinea-pigs. Psychopharmacology (Berlin) 107:581-590.
7. Bruchas MR, Land BB, Lemos JC, and Chavkin C (2009) CRF1-R activation of the dynorphin/κ opioid system in the mouse basolateral amygdala mediates anxietylike behavior. PLoS One 4:e8528.
8. Butelman ER, Mandau M, Tidgewell K, Prisinzano TE, Yuferov V, and Kreek MJ (2007) Effects of salvinorin A, a κ-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high κ-receptor homology to humans. J Pharmacol Exp Ther 320:300-306.
9. Carr GV, Bangasser DA, Bethea T, Young M, Valentino RJ, and Lucki I (2010) Antidepressant-like effects of κ-opioid receptor antagonists in Wistar Kyoto rats. Neuropsychopharmacology 35:752-763.
10. Carr GV and Lucki I (2010) Comparison of the κ-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats. Psychopharmacology (Berl) 210:295-302.
11. Clemente JT, Parada CA, Veiga MC, Gear RW, and Tambeli CH (2004) Sexual dimorphism in the antinociception mediated by κ opioid receptors in the rat temporomandibular joint. Neurosci Lett 372:250-255.
12. Contreras M, Ceric F, and Torrealba F (2008) [The negative side of emotions: addiction to drugs of abuse]. Rev Neurol 47:471-476.
13. Craft RM (2008) Sex differences in analgesic, reinforcing, discriminative, and motoric effects of opioids. Exp Clin Psychopharmacol 16:376-385.
14. Craft RM and Bernal SA (2001) Sex differences in opioid antinociception: κ and 'mixed action' agonists. Drug Alcohol Depend 63:215-228.
15. Craft RM, Kruzich PJ, Boyer JS, Harding JW, and Hanesworth JM (1998) Sex differences in discriminative stimulus and diuretic effects of the κ opioid agonist U69,593 in the rat. Pharmacol Biochem Behav 61:395-403.
16. Craft RM, Tseng AH, McNiel DM, Furness MS, and Rice KC (2001) Receptorselective antagonism of opioid antinociception in female versus male rats. Behav Pharmacol 12:591-602.
17. Crick FC and Koch C (2005) What is the function of the claustrum? Philos Trans R Soc Lond B Biol Sci 360:1271-1279.
18. Dahan A, Kest B, Waxman AR, and Sarton E (2008) Sex-specific responses to opiates: animal and human studies. Anesth Analg 107:83-95.
19. Di Chiara G and Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274-5278.
20. Elliott JC, Picker MJ, Sparrow AJ, and Lysle DT (2006a) Dissociation between sex differences in the immunological, behavioral, and physiological effects of κ- and δ-opioids in Fischer rats. Psychopharmacology (Berl) 185:66-75.
21. Elliott JC, Wagner AF, and Lysle DT (2006b) Neurokinin 1 receptor signaling mediates sex differences in μ and κ opioid-induced enhancement of contact hypersensitivity. J Neuroimmunol 181:100-105.
22. Endoh T, Matsuura H, Tanaka C, and Nagase H (1992) Nor-binaltorphimine: a potent and selective κ-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther 316:30-42.
23. Fillingim RB, Hastie BA, Ness TJ, Glover TL, Campbell CM, and Staud R (2005) Sex-related psychological predictors of baseline pain perception and analgesic responses to pentazocine. Biol Psychol 69:97-112.
24. Fillingim RB, Ness TJ, Glover TL, Campbell CM, Price DD, and Staud R (2004) Experimental pain models reveal no sex differences in pentazocine analgesia in humans. Anesthesiology 100:1263-1270.
25. Fitzgerald PB, Laird AR, Maller J, and Daskalakis ZJ (2008) A meta-analytic study of changes in brain activation in depression. Hum Brain Mapp 29:683-695.
26. Gear RW, Gordon NC, Heller PH, Paul S, Miaskowski C, and Levine JD (1996a) Gender difference in analgesic response to the κ-opioid pentazocine. Neurosci Lett 205:207-209.
27. Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, and Levine JD (1996b) Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med 2:1248-1250.
28. Gioiosa L, Chen X, Watkins R, Umeda EA, and Arnold AP (2008) Sex chromosome complement affects nociception and analgesia in newborn mice. J Pain 9:962-969.
29. Goodman RR and Snyder SH (1982a) Autoradiographic localization of κ opiate receptors to deep layers of the cerebral cortex may explain unique sedative and analgesic effects. Life Sci 31:1291-1294.
30. Goodman RR and Snyder SH (1982b) Kappa opiate receptors localized by autoradiography to deep layers of cerebral cortex: relation to sedative effects. Proc Natl Acad Sci U S A 79:5703-5707.
31. Harned MA and Casida LE (1972) Failure to obtain group synchrony of estrus in the guinea pig. J Mammal 53:223-225.
32. Hayes AG, Sheehan MJ, and Tyers MB (1987) Differential sensitivity of models of antinociception in the rat, mouse, and guinea-pig to μ- and κ-opioid receptor agonists. Br J Pharmacol 91:823-832.
33. Huang P, Liu-Chen LY, Unterwald EM, and Cowan A (2009) Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from Δ9-tetrahydrocannabinol in C57BL/6 mice. Neurosci Lett 465:66-70.
34. Huang P, Xu W, Yoon SI, Chen C, Chong PL, Unterwald EM, and Liu-Chen LY (2007) Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells. Brain Res 1184:46-56.
35. 3H]U-69593 as a binding ligand. Eur J Pharmacol 175:93-96.
36. Knoll AT, Meloni EG, Thomas JB, Carroll FI, and Carlezon WA Jr (2007) Anxiolyticlike effects of κ-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther 323:838-845.
37. Kreek MJ, Schluger J, Borg L, Gunduz M, and Ho A (1999) Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions. J Pharmacol Exp Ther 288:260-269.
38. Lavalaye J, Booij J, Reneman L, Habraken JB, and van Royen EA (2000) Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur J Nucl Med 27:867-869.
39. Lilley KG, Epping RJ, and Hafner LM (1997) The guinea pig estrous cycle: correlation of vaginal impedance measurements with vaginal cytologic findings. Lab Anim Sci 47:632-637.
40. Liu-Chen LY (2004) Agonist-induced regulation and trafficking of κ opioid receptors. Life Sci 75:511-536.
41. Loyd DR and Murphy AZ (2009) The role of the periaqueductal gray in the modulation of pain in males and females: are the anatomy and physiology really that different? Neural Plast 2009:462879.
42. Loyd DR, Wang X, and Murphy AZ (2008) Sex differences in micro-opioid receptor expression in the rat midbrain periaqueductal gray are essential for eliciting sex differences in morphine analgesia. J Neurosci 28:14007-14017.
43. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, Jones RM, Portoghese PS, and Carlezon WA Jr (2003) Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305:323-330.
44. Maher CE, Martin TJ, and Childers SR (2005) Mechanisms of μ opioid receptor/Gprotein desensitization in brain by chronic heroin administration. Life Sci 77: 1140-1154.
45. Mansour A, Khachaturian H, Lewis ME, Akil H, and Watson SJ (1988) Anatomy of CNS opioid receptors. Trends Neurosci 11:308-314.
46. Manzanares J, Wagner EJ, Moore KE, and Lookingland KJ (1993) Kappa opioid receptor-mediated regulation of prolactin and α-melanocyte-stimulating hormone secretion in male and female rats. Life Sci 53:795-801.
47. McLaughlin JP, Land BB, Li S, Pintar JE, and Chavkin C (2006) Prior activation of κ opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology 31:787-794.
48. McLaughlin JP, Marton-Popovici M, and Chavkin C (2003) Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23:5674-5683.
49. Mucha RF and Herz A (1985) Motivational properties of κ and μ opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology (Berl) 86:274-280.
50. Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, Nanjo K, Matsuzawa K, Yamazaki M, and Suzuki T (2006) Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 31:739-750.
51. Negus SS, Zuzga DS, and Mello NK (2002) Sex differences in opioid antinociception in rhesus monkeys: antagonism of fentanyl and U50,488 by quadazocine. J Pain 3:218-226.
52. Nelson JF, Felicio LS, Randall PK, Sims C, and Finch CE (1982) A longitudinal study of estrous cyclicity in aging C57BL/6J mice: I. Cycle frequency, length and vaginal cytology. Biol Reprod 27:327-339.
53. Neumeyer JL, Mello NK, Negus SS, and Bidlack JM (2000) Kappa opioid agonists as targets for pharmacotherapies in cocaine abuse. Pharm Acta Helv 74:337-344.
54. Parent A and Carpenter MB (1996) Carpenter's Human Neuroanatomy, Williams Wilkins, Baltimore, MD.
55. Paxinos G and Franklin KBJ (1997) The Mouse Brain in Stereotaxic Coodinates Deluxe Edition of the Atlas, Academic Press, San Diego, CA.
56. Pfeiffer A, Brantl V, Herz A, and Emrich HM (1986) Psychotomimesis mediated by κ opiate receptors. Science 233:774-776.
57. Prather PL, McGinn TM, Claude PA, Liu-Chen LY, Loh HH, and Law PY (1995) Properties of a κ-opioid receptor expressed in CHO cells: interaction with multiple G-proteins is not specific for any individual Gα subunit and is similar to that of other opioid receptors. Mol Brain Res 29:336-346.
58. Puig-Ramos A, Santiago GS, and Segarra AC (2008) U-69593, a κ opioid receptor agonist, decreases cocaine-induced behavioral sensitization in female rats. Behav Neurosci 122:151-160.
59. Quirion R and Pilapil C (1991) Distribution of multiple opioid receptors in the human brain, in Receptors in the Human Nervous System (Mendelsohn FAO and Paxinos G eds) pp 103-121, Academic Press, San Diego, CA.
60. 3H]bremazocine. Cell Mol Neurobiol 7:303-307.
61. Rasakham K and Liu-Chen LY (2011) Sex differences in κ opioid pharmacology. Life Sci 88:2-16.
62. Rivest R, Falardeau P, and Di Paolo T (1995) Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain Res 692:269-272.
63. Rottmann M, Fábián G, Spicher K, Offermanns S, and Szücs M (1998) Receptormediated activation of G-proteins by κ opioid agonists in frog (Rana esculenta) brain membranes. Brain Res Bull 45:467-474.
64. Schindler CW and Carmona GN (2002) Effects of dopamine agonists and antagonists on locomotor activity in male and female rats. Pharmacol Biochem Behav 72:857-863.
65. Sell SL, Scalzitti JM, Thomas ML, and Cunningham KA (2000) Influence of ovarian hormones and estrous cycle on the behavioral response to cocaine in female rats. J Pharmacol Exp Ther 293:879-886.
66. Sershen H, Hashim A, and Lajtha A (1998) Gender differences in κ-opioid modulation of cocaine-induced behavior and NMDA-evoked dopamine release. Brain Res 801:67-71.
67. Sharp T, Zetterström T, Ljungberg T, and Ungerstedt U (1987) A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res 401:322-330.
68. Shin SH, Obonsawin MC, Van Vugt DA, Baby N, and Jhamandas K (1988) Morphine can stimulate prolactin release independent of a dopaminergic mechanism. Can J Physiol Pharmacol 66:1381-1385.
69. Shippenberg TS, Zapata A, and Chefer VI (2007) Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther 116:306-321.
70. 35S] guanylyl-5′-O-(γ-thio)-triphosphate binding in guinea pig brain. J Comp Neurol 386:562-572.
71. 35S]thio]- triphosphate binding. Proc Natl Acad Sci U S A 92:7242-7246.
72. 35S] GTPγS autoradiography in rat brain. J Neurosci 16:2684-2692.
73. Sim-Selley LJ, Selley DE, Vogt LJ, Childers SR, and Martin TJ (2000) Chronic heroin self-administration desensitizes μ opioid receptor-activated G-proteins in specific regions of rat brain. J Neurosci 20:4555-4562.
74. Slowe SJ, Simonin F, Kieffer B, and Kitchen I (1999) Quantitative autoradiography of μ-, δ- and κ1 opioid receptors in κ-opioid receptor knockout mice. Brain Res 818:335-345.
75. Svingos AL, Chavkin C, Colago EE, and Pickel VM (2001) Major coexpression of κ-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles. Synapse 42:185-192.
76. Tao PL, Hwang CL, and Chen CY (1994) U-50,488 blocks the development of morphine tolerance and dependence at a very low dose in guinea pigs. Eur J Pharmacol 256:281-286.
77. Thompson AC, Zapata A, Justice JB Jr, Vaughan RA, Sharpe LG, and Shippenberg TS (2000) Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine. J Neurosci 20:9333-9340.
78. Unterwald EM, Knapp C, and Zukin RS (1991) Neuroanatomical localization of κ1 and κ2 opioid receptors in rat and guinea pig brain. Brain Res 562:57-65.
79. Vogt LJ, Sim-Selley LJ, Childers SR, Wiley RG, and Vogt BA (2001) Colocalization of μ-opioid receptors and activated G-proteins in rat cingulate cortex. J Pharmacol Exp Ther 299:840-848.
80. Walker QD, Ray R, and Kuhn CM (2006) Sex differences in neurochemical effects of dopaminergic drugs in rat striatum. Neuropsychopharmacology 31:1193-1202.
81. Wang Y, Van Bockstaele EJ, and Liu-Chen LY (2008) In vivo trafficking of endogenous opioid receptors. Life Sci 83:693-699.
82. Wang Y, Xu W, Huang P, Chavkin C, Van Bockstaele EJ, and Liu-Chen LY (2009) Effects of acute agonist treatment on subcellular distribution of κ opioid receptor in rat spinal cord. J Neurosci Res 87:1695-1702.
83. Wittmann W, Schunk E, Rosskothen I, Gaburro S, Singewald N, Herzog H, and Schwarzer C (2009) Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone. Neuropsychopharmacology 34:775-785.
84. 35S] GTPγS binding to membranes: determination of potencies and efficacies of ligands. J Pharmacol Exp Ther 282: 676-684.
85. Zukin RS, Eghbali M, Olive D, Unterwald EM, and Tempel A (1988) Characterization and visualization of rat and guinea pig brain κ opioid receptors: evidence for κ1 and κ2 opioid receptors. Proc Natl Acad Sci U S A 85:4061-4065.